Fig. 1
From: Mesenchymal stem cell-mediated delivery of therapeutic adenoviral vectors to prostate cancer
Percentage viability assay: a, b Viability of cells was measured by MTT assay after 48 h treatment of C4–2 and LNCaP cells with adenoviral vectors at 50 and 100 MOI. Histograms show that compared to control, the viability of treated cells significantly decreased at 100 MOI. Data in histograms represent the average of triplicate samples, with standard deviations shown (*P < 0.05)